Literature DB >> 11805172

Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.

Frédéric D Debelle1, Joëlle L Nortier1, Eric G De Prez1, Christian H Garbar1, Anne R Vienne1, Isabelle J Salmon1, Monique M Deschodt-Lanckman1, Jean-Louis Vanherweghem1.   

Abstract

Chinese-herb nephropathy (CHN) is a rapidly progressive renal fibrosis associated with the intake of a Chinese herb (Aristolochia fangchi) containing nephrotoxic and carcinogenic aristolochic acids (AA). This study attempted to reproduce the main features of human CHN (renal failure, tubular atrophy, and interstitial fibrosis) in a rat model similar to that of cyclosporin-induced nephropathy. Salt-depleted male Wistar rats received daily subcutaneous injections of either 1 mg/kg body wt AA (low-dose AA group), 10 mg/kg body wt AA (high-dose AA group), or vehicle (control group) for 35 d. On days 10 and 35, assessment of renal function, measurements of urinary excretion of glucose, protein, and leucine aminopeptidase, and histologic analyses were performed (six rats euthanized/group). High-dose AA induced glucosuria, proteinuria, and elevated serum creatinine levels and reduced leucine aminopeptidase enzymuria on days 10 and 35, whereas low-dose AA had no significant effect. Tubular necrosis associated with lymphocytic infiltrates (day 10) and tubular atrophy surrounded by interstitial fibrosis (day 35) were the histologic findings for the high-dose AA-treated rats. In both AA groups, urothelial dysplasia was also observed, as well as fibrohistiocytic sarcoma at the injection site. A short-term model of AA-induced renal fibrosis was established in salt-depleted Wistar rats. These results support the role of AA in human CHN and provide a useful model for examination of the pathophysiologic pathways of renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805172     DOI: 10.1681/ASN.V132431

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  57 in total

1.  Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.

Authors:  Wan Chan; Yufang Zheng; Zongwei Cai
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-05       Impact factor: 3.109

2.  Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease.

Authors:  Laura I Neumeier; Robert B Thomson; Martin Reichel; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

3.  Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Authors:  Alessandra Scarpellini; Linghong Huang; Izhar Burhan; Nina Schroeder; Muriel Funck; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

4.  Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Authors:  Bojan Jelaković; Xavier Castells; Karla Tomić; Maude Ardin; Sandra Karanović; Jiri Zavadil
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

Review 5.  Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Authors:  Omid Sadeghi-Alavijeh; Mohammad Tadayyon; Ben Caplin
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

6.  A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors:  D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-22       Impact factor: 3.000

7.  A meta-analysis of medicinal plants to assess the evidence for toxicity.

Authors:  Sarah Chen; Amandio Vieira
Journal:  Interdiscip Toxicol       Date:  2010-06

Review 8.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

10.  beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.

Authors:  Ying Xiao; Xiang Xue; Yuan-feng Wu; Guo-zheng Xin; Yong Qian; Tian-pei Xie; Li-kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.